FDA approves migraine indication for Botox

FDA approved an sBLA from Allergan Inc. (NYSE:AGN) for Botox onabotulinumtoxinA to treat chronic migraine. Botox is already approved in the U.S. to treat severe primary axillary hyperhidrosis, cervica...